HRS4R
Vull donar

JORDI RUBIÓ CASADEVALL

Firma
JORDI RUBIÓ-CASADEVALL
Posició
Investigador/a Consolidat - R3
Investigador/a Consolidat - R3

Publicacions

Rubio-Casadevall, J, Trallero, J, Calvo, C, Puigdemont, M, Carulla, M, Sanvisens, A, Ameijide, A, Vidal, A, Pla, C, Marruecos, J, Marcos-Gragera, R, Galceran, J

A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018

Clinical & Translational Oncology, 2025, 27, 3410-3420 dx.doi.org/10.1007/s12094-025-03855-8
Indini A, Didoné F, Massi D, Puig S, Casadevall JR, Bennett D, Katalinic A, Sanvisens A, Ferrari A, Lasalvia P, Demuru E, Ragusa R, Mayer-da-Silva A, Blum M, Mousavi M, Kuehni C, Mihor A, Mandalà M, Trama A

Corrigendum to "Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results" [Eur J Cancer 213 (2024):115079].

EUROPEAN JOURNAL OF CANCER, 2025, 218, 115295-115295 dx.doi.org/10.1016/j.ejca.2025.115295
Stefanovic M, Hernando-Calvo A, Castro JB, Huang SH, Su J, O'Sullivan B, Ringash J, Galiana IL, Borbalas AL, Cirauqui BC, Hahn E, Teruel I, de Almeida JR, Querol JM, Witterick IJ, Rubió-Casadevall J, Goldstein DP, Siu LL, Waldron J, Oliva M, Spreafico A

Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis.

Laryngoscope, 2025 dx.doi.org/10.1002/lary.70044
Marruecos Querol J, Jurado-Bruggeman D, Lopez-Vidal A, Mesía Nin R, Rubió-Casadevall J, Buxó M, Eraso Urien A

Contouring aid tools in radiotherapy. Smoothing: the false friend

Clinical & Translational Oncology, 2024, 26, 1956-1967 dx.doi.org/10.1007/s12094-024-03420-9
Alonso-Gordoa T, Jimenez-Fonseca P, Martinez-Trufero J, Navarro M, Porras I, Rubió-Casadevall J, Arregui Valles M, Basté N, Hernando J, Iglesias Docampo L

SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023).

Clinical & Translational Oncology, 2024, 26, 2902-2916 dx.doi.org/10.1007/s12094-024-03736-6
Indini A, Didoné F, Massi D, Puig S, Casadevall JR, Bennett D, Katalinic A, Sanvisens A, Ferrari A, Lasalvia P, Demuru E, Ragusa R, Mayer-da-Silva A, Blum M, Mousavi M, Kuehni C, Mihor A, Mandalà M, Trama A

Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.

EUROPEAN JOURNAL OF CANCER, 2024, 213, 115079-115079 dx.doi.org/10.1016/j.ejca.2024.115079
Marruecos-Querol J, Rubió-Casadevall J, Lozano A, Buxó M, Puigdemont M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Borés A, Recalde S, Saigi M, Felip E, Eraso A, Mesía R

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population

Clinical & Translational Oncology, 2023, 25, 2384-2392 dx.doi.org/10.1007/s12094-023-03121-9
Rubió-Casadevall J, Cirauqui Cirauqui B, Martinez Trufero J, Plana Serrahima M, García Castaño A, Carral Maseda A, Iglesias Docampo L, Pérez Segura P, Ceballos Lenza I, Gutiérrez Calderón V, Fuster Salvà J, Pena Álvarez C, Hernandez I, Del Barco Morillo E, Chaves Conde M, Martínez Galán J, Durán Sánchez M, Quiroga V, Ortega E, Mesia R

TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck

Frontiers in oncology, 2023, 13, 1226939-1226939 dx.doi.org/10.3389/fonc.2023.1226939
Serrano C, Martín-Broto J, Asencio-Pascual JM, López-Guerrero JA, Rubió-Casadevall J, Bagué S, García-Del-Muro X, Fernández-Hernández JÁ, Herrero L, López-Pousa A, Poveda A, Martínez-Marín V

2023 GEIS Guidelines for gastrointestinal stromal tumors

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15 dx.doi.org/10.1177/17588359231192388
Botta L, Matsuda T, Charvat H, Chiang CJ, Lee WC, van Gestel AJ, Martin F, Geleijnse G, Cellamare M, Bonfarnuzzo S, Marcos-Gragera R, Guevara M, Mousavi M, Craig S, Rodrigues J, Rubió-Casadevall J, Licitra L, Cavalieri S, Resteghini C, Gatta G, Trama A, RARECAREnet working group

Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure.

Frontiers in oncology, 2023, 13, 1219111-1219111 dx.doi.org/10.3389/fonc.2023.1219111

Formulari de contacte

Coneix l’IDIBGI!

menu